<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">127026</id>
  <title nil="true"/>
  <common-name>(1-Methylethylidene)bis[(2-methyl-4,1-phenylene)oxy(1-methyl-2,1-ethanediyl)] bismethacrylate</common-name>
  <description>(1-Methylethylidene)bis[(2-methyl-4,1-phenylene)oxy(1-methyl-2,1-ethanediyl)] bismethacrylate belongs to the diphenylmethanes, a subclass of benzene and substituted derivatives within the organic compounds. It is a benzenoid with the formula C31H40O6. With an average molecular weight of 508.60 g/mol, (1-Methylethylidene)bis[(2-methyl-4,1-phenylene)oxy(1-methyl-2,1-ethanediyl)] bismethacrylate is a heavy molecule.</description>
  <cas>70146-06-4</cas>
  <pubchem-id>112194</pubchem-id>
  <chemical-formula>C31H40O6</chemical-formula>
  <weight>508.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-04-06T10:52:44Z</created-at>
  <updated-at type="dateTime">2026-08-31T17:30:36Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1=C(C=CC(=C1)C(C)(C)C2=CC(=C(C=C2)OCC(C)OC(=O)C(=C)C)C)OCC(C)OC(=O)C(=C)C</moldb-smiles>
  <moldb-formula>C31H40O6</moldb-formula>
  <moldb-inchi>InChI=1S/C31H40O6/c1-19(2)29(32)36-23(7)17-34-27-13-11-25(15-21(27)5)31(9,10)26-12-14-28(22(6)16-26)35-18-24(8)37-30(33)20(3)4/h11-16,23-24H,1,3,17-18H2,2,4-10H3</moldb-inchi>
  <moldb-inchikey>CUUNNZSQCSCH-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">508.282489</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>8</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM122919</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00120845</susdat-id>
  <iupac>1-[2-methyl-4-[2-[3-methyl-4-[2-(2-methylprop-2-enoyloxy)propoxy]phenyl]propan-2-yl]phenoxy]propan-2-yl 2-methylprop-2-enoate</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Benzenoids</superklass>
  <klass>Benzene and substituted derivatives</klass>
  <subklass>Diphenylmethanes</subklass>
  <paper-count type="integer">0</paper-count>
  <sync-id>CED0095317</sync-id>
  <structure-inchikey>CUUNNZSQCNASCH-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>408000000000004004008002000022000000000000000000000000000000000000000010000000080000000000000000008000000000000000000000000000000000000000000000000000000000000000200000010001000000000000000000000000000100000000000000001000000000000000000000000000000000004200000000c0000800000000000000000000000000000000000000000000000000000000000020000000400200080100000040000000080080000000000000400000000000000000000040000000000000400000000000002800000200000000000000000000000000000040000000000500000000000020000000000800000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAlAAAAJgAAAIABBgBgAAAAAQMGQCgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T04:48:04Z</structure-indexed-at>
</compound>
